BioCryst Pharmaceuticals (BCRX)
(Delayed Data from NSDQ)
$7.52 USD
-0.33 (-4.20%)
Updated Jul 29, 2024 04:00 PM ET
After-Market: $7.51 -0.01 (-0.13%) 7:58 PM ET
1-Strong Buy of 5 1
F Value C Growth F Momentum F VGM
Detailed Estimates
EPS Estimates
Earnings Date | *BMO8/5/24 |
---|---|
Current Quarter | -0.19 |
EPS Last Quarter | -0.17 |
Last EPS Surprise | 26.09% |
ABR | 1.50 |
Earnings ESP
|
-8.62% |
---|---|
Current Year | -0.65 |
Next Year | -0.35 |
EPS (TTM) | -0.88 |
P/E (F1) | NA |
Sales Estimates
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | 98.27M | 103.65M | 403.65M | 492.63M |
# of Estimates | 5 | 5 | 5 | 5 |
High Estimate | 101.09M | 105.81M | 408.07M | 512.18M |
Low Estimate | 96.66M | 102.36M | 399.09M | 472.19M |
Year ago Sales | 82.49M | 86.74M | 331.41M | 403.65M |
Year over Year Growth Est. | 19.13% | 19.50% | 21.80% | 22.04% |
Earnings Estimates
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | -0.19 | -0.15 | -0.65 | -0.35 |
# of Estimates | 6 | 5 | 7 | 6 |
Most Recent Consensus | -0.14 | -0.10 | -0.51 | -0.08 |
High Estimate | -0.14 | -0.10 | -0.51 | -0.08 |
Low Estimate | -0.32 | -0.19 | -0.76 | -0.65 |
Year ago EPS | -0.24 | -0.19 | -1.00 | -0.65 |
Year over Year Growth Est. | 20.83% | 21.05% | 35.00% | 45.71% |
Agreement - Estimate Revisions
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Up Last 7 Days | 0 | 0 | 0 | 0 |
Up Last 30 Days | 0 | 0 | 1 | 1 |
Up Last 60 Days | 0 | 0 | 1 | 1 |
Down Last 7 Days | 0 | 0 | 0 | 0 |
Down Last 30 Days | 1 | 1 | 0 | 0 |
Down Last 60 Days | 1 | 1 | 0 | 0 |
Magnitude - Consensus Estimate Trend
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Current | -0.19 | -0.15 | -0.65 | -0.35 |
7 Days Ago | -0.19 | -0.15 | -0.65 | -0.35 |
30 Days Ago | -0.19 | -0.15 | -0.66 | -0.36 |
60 Days Ago | -0.19 | -0.15 | -0.66 | -0.36 |
90 Days Ago | -0.16 | -0.15 | -0.69 | -0.34 |
Upside - Most Accurate Estimate Versus Zacks Consensus
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Most Accurate Estimate | -0.21 | -0.19 | -0.76 | -0.65 |
Zacks Consensus Estimate | -0.19 | -0.15 | -0.65 | -0.35 |
Earnings ESP | -8.62% | -25.00% | -17.44% | -85.71% |
Surprise - Reported Earnings History
Quarter Ending (3/2024) |
Quarter Ending (12/2023) |
Quarter Ending (9/2023) |
Quarter Ending (6/2023) |
Average Surprise | |
---|---|---|---|---|---|
Reported | -0.17 | -0.28 | -0.19 | -0.24 | NA |
Estimate | -0.23 | -0.24 | -0.25 | -0.25 | NA |
Difference | 0.06 | -0.04 | 0.06 | 0.01 | 0.02 |
Surprise | 26.09% | -16.67% | 24.00% | 4.00% | 9.36% |
Annual Estimates By Analyst
Zacks Premium Subscription Required Learn more